Viewing Study NCT00005869


Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2026-01-01 @ 8:04 AM
Study NCT ID: NCT00005869
Status: UNKNOWN
Last Update Posted: 2013-12-04
First Post: 2000-06-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Sponsor: Astex Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module